Brian Holben

[Penumbra Vascular @PenVascular]

US HCPs: 📢 Dr. Charles Bailey presented the latest THRIVE Study data at #VAM25: CAVT patients had up to 55% fewer 30-day ALI readmissions vs. Embolectomy. Learn more about #CAVT https://t.co/J6skuzk83A

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary.

[Penumbra Vascular @PenVascular]

#TheCompletePEStory resonates within the field! Let’s focus on optimizing patient outcomes and minimizing complications. #LeadWithCAVT #SpeedMatters

[Brian Holben @HolbenBrian]

@UvaVascular Congrats Dr. Tracci

[Penumbra Vascular @PenVascular]

US HCPs: NOW introducing #LightningBolt6X with TraX and #LightningBolt12, the newest additions to your complete #CAVT platform for the management of arterial and venous thrombus. #LeadWithCAVT #BOLTMode

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[The PERT Consortium® @PERTConsortium]

Summary of first 300 STRIKE-PE patients: short, safe, symptomatic improvement #PERT2024 @JonnyMoriarty

[The PERT Consortium® @PERTConsortium]

Sohail Dohad is next up detailing the results of a study looking at blood reinfusion following mechanical thrombectomy. #PERT2024 Is it all it’s cracked up to be?

[Penumbra Vascular @PenVascular]

US HCPs: Penumbra’s philosophy on PE thrombectomy has never been to autotransfuse blood but to optimize clot removal and minimize EBL. #TheCompletePEStory

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[W. Darrin Clouse @WDarrinClouse]

OPEN RANK FACULTY POSITION, DIVISION OF VASCULAR AND ENDOVASCULAR SURGERY Job University of Virginia.
Come join our team! Practice gamut of academic vascular surgery! Opportunity to lead limb program! You go ⁦@UvaVascular⁩ ⁦⁦@UVASurgery⁩ https://t.co/ihLHkYc8Gq

[Penumbra Vascular @PenVascular]

US HCPs: 👀 The latest STRIDE subset analysis showing no difference in Indigo frontline vs Indigo + overnight tPA. Further proves the impact of frontline #SingleSession therapy w/ the Indigo System #FrontlineALI

Rx only Risk info https://t.co/SILdiRZWwC Clinical results may vary

[Penumbra Vascular @PenVascular]

Register for tomorrow's webinar to discuss the treatment of PE, sponsored by @PERTConsortium and @SVM_tweets. #CAVT

Link to register: https://t.co/zjK3ihIspy

[Penumbra Vascular @PenVascular]

US HCPs: Congratulations to Dr. Sameh Sayfo at @bswhealth on this bilateral PE thrombectomy with a 5-minute device time! ⚡ Lightning Flash 2.0, designed for Speed, Safety, and Simplicity. #CAVT #GallopMode

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: ⚡ Lightning Flash 2.0, designed for Speed, Safety, and Simplicity. Congrats to Dr. Abindra Sigdel at UofL Jewish Hospital on this venous thrombectomy with a 4-minute device time! #CAVT #GallopMode  

Rx only. Risk info: https://t.co/SILdiRZWwC Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: Congrats to Dr. Robert Sanchez at @uthealtheasttx on this bilateral PE! ⚡ Lightning Flash 2.0, next-gen software for the treatment of PE. #CAVT #GallopMode

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: 🚨 STRIDE data introduces a new standard of care for patients with acute limb ischemia (ALI) by demonstrating clinical advantages to the traditional open surgical approach. #CAVT #LightningBolt7

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

Today, in collaboration with #SIRFoundation and @VIVAPhysicians, we launched EMBOLIZE. This 1st-of-its-kind prospective RCT will study the effects of ovarian vein embolization in women experiencing chronic pain due to pelvic venous disease: https://t.co/LWvPP4Mbgo #SIR24SLC

[Brian Holben @HolbenBrian]

@ashkan_1670 @DHidlayVIR I think you need to come back and visit Charlottesville.

[Penumbra Vascular @PenVascular]

US HCPs: Thank you to Dr. Kalyan Veerina at Opelousas General Hospital for sharing this great #LightningFlash case! ⚡ #FeelThePower with #CAVT

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Brian Holben @HolbenBrian]

I'm committed to kidney disease. Take this assessment from @Medtronic partner, National Kidney Foundation, to see your risk for kidney disease. https://t.co/CZrsNmHxJ0 #NationalKidneyMonth #MedtronicEmployee

[Brian Holben @HolbenBrian]

@MikeKelly_CVIR @_backtable @AVIRnews @kmadass @angiowoman @SDhandMD @AaronFrittsMD @LessneVIR @t_intheleadcoat @keithppereira @BDixonMD @SIRspecialists Sad I missed it this year.

[Brian Holben @HolbenBrian]

I'm excited that Medtronic is partnering with National Kidney Foundation to help raise awareness of kidney disease. https://t.co/O7q3zpZZ6P #NationalKidneyMonth #MedtronicEmployee